BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30206756)

  • 1. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
    Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients.
    Ainthachot S; Sa-Ngiamwibool P; Thanee M; Watcharadetwittaya S; Chamgramol Y; Pairojkul C; Deenonpoe R
    Hum Pathol; 2022 Aug; 126():31-44. PubMed ID: 35577140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma.
    Deenonpoe R; Sa-Ngiamwibool P; Watcharadetwittaya S; Thanee M; Intuyod K; Kongpan T; Padthaisong S; Nutalai R; Chamgramol Y; Pairojkul C
    Sci Rep; 2022 May; 12(1):8441. PubMed ID: 35589822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
    Zhai J
    Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
    Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
    World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
    Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.
    Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M
    World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
    Kaneko R; Sato Y; Kobayashi Y
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
    Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
    Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern diagnostic approaches to cholangiocarcinoma.
    Vasilieva LE; Papadhimitriou SI; Dourakis SP
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):349-59. PubMed ID: 22893461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
    Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
    Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.
    Muenphon K; Limpaiboon T; Jearanaikoon P; Pairojkul C; Sripa B; Bhudhisawasdi V
    World J Gastroenterol; 2006 Jul; 12(26):4143-8. PubMed ID: 16830362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.